CTEVClaritev Corporation
$23.49-64% 1Y
$23.49
$13.4752 weeks$71.36
Is the price fair?
What CTEV's price assumes
Claritev Corporation did not earn a profit over the last twelve months, so it has no trailing P/E and the price is measured against sales instead: 0.58× revenue.
0.58
Price / sales · no P/E: the last twelve months did not end in a profit
- EV / sales
- 5.19
EV / sales
Details›
- EV / EBITas of 2026-Q2
- 159
- EV / salesas of 2026-Q2
- 5.19
- Market capitalisation16.9 million shares, counted Aug 3, 2026
- $398M
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Health Information Services
Ranks #11 of 18 by RyuScore